Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). (Q47747733)

5 February 2018

title

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). (English)

1 reference

5 February 2018

metabolic dysfunction–associated steatotic liver disease

main subject

patient

0 references

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

Maria Stepanova

1

1 reference

5 February 2018

Nila Rafiq

2

1 reference

5 February 2018

Hala Makhlouf

3

1 reference

5 February 2018

Ritambhara Agrawal

4

1 reference

5 February 2018

Ishmeet Kaur

5

1 reference

5 February 2018

Zahra Younoszai

6

1 reference

5 February 2018

Arthur McCullough

7

1 reference

5 February 2018

Zachary Goodman

8

1 reference

5 February 2018

Zobair M Younossi

9

1 reference

5 February 2018

publication date

18 June 2013

1 reference

5 February 2018

Digestive Diseases and Sciences

published in

1 reference

5 February 2018

volume

58

1 reference

5 February 2018

page(s)

3017-3023

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s10620-013-2743-5

exact match

0 references

cites work

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Epidemiology and natural history of NAFLD and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Effects of weight loss on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Prevalence, gender, ethnic variations, and prognosis of NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Nonalcoholic fatty liver disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Treatment options for nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2743-5

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

12 December 2020

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

1 reference

12 December 2020

Deaths: final data for 2007.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a practical approach to evaluation and management

1 reference

12 December 2020

A 2012 clinical update for internists in adult nonalcoholic fatty liver disease.

1 reference

12 December 2020

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

12 December 2020

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease

1 reference

12 December 2020

Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes

1 reference

12 December 2020

10.1007/S10620-013-2743-5

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

23775317

1 reference

5 February 2018